The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell …
X Zhang, J Chen, MZ Han, H Huang, E Jiang… - Journal of hematology & …, 2021 - Springer
The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH)
on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem …
on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem …
Granulocyte colony-stimulating factor-primed unmanipulated haploidentical blood and marrow transplantation
YJ Chang, XY Zhao, XJ Huang - Frontiers in Immunology, 2019 - frontiersin.org
Granulocyte colony-stimulating factor (G-CSF), a growth factor for neutrophils, has been
successfully used for stem cell mobilization and T cell immune tolerance induction. The …
successfully used for stem cell mobilization and T cell immune tolerance induction. The …
Single-cell immune landscape of measurable residual disease in acute myeloid leukemia
X Mo, W Zhang, G Fu, Y Chang, X Zhang, L Xu… - Science China Life …, 2024 - Springer
Measurable residual disease (MRD) is a powerful prognostic factor of relapse in acute
myeloid leukemia (AML). We applied the single-cell RNA sequencing to bone marrow (BM) …
myeloid leukemia (AML). We applied the single-cell RNA sequencing to bone marrow (BM) …
Haploidentical stem cell transplantation for acute myeloid leukemia: current therapies, challenges and future prospective
YJ Chang, XY Zhao, XJ Huang - Frontiers in Oncology, 2021 - frontiersin.org
Haploidentical stem cell transplantation (haplo-SCT), an alternative donor source, offers a
curative therapy for patients with acute myeloid leukemia (AML) who are transplant …
curative therapy for patients with acute myeloid leukemia (AML) who are transplant …
Treatment options for adult intermediate-risk AML patients in CR1: Allo-HSCT or chemotherapy?
L Wang, C Zhang, S Fan, X Mo, X Hu - The Innovation, 2023 - cell.com
* Correspondence: moxiaodong@ bjmu. edu. cn (XM); hxx12276@ rjh. com. cn (XH)
Received: May 11, 2023; Accepted: June 18, 2023; Published Online: June 20, 2023; …
Received: May 11, 2023; Accepted: June 18, 2023; Published Online: June 20, 2023; …
Association between measurable residual disease in patients with intermediate-risk acute myeloid leukemia and first remission, treatment, and outcomes
S Yu, Z Fan, L Ma, Y Wang, F Huang… - JAMA Network …, 2021 - jamanetwork.com
Importance Measurable residual disease (MRD) is widely used as a therapy-stratification
factor for acute myeloid leukemia (AML), but the association of dynamic MRD with …
factor for acute myeloid leukemia (AML), but the association of dynamic MRD with …
Comparison of haploidentical hematopoietic stem cell transplantation with chemotherapy in older adults with acute myeloid leukemia
YQ Sun, XH Zhang, Q Jiang, H Jiang… - Bone Marrow …, 2023 - nature.com
Acute myeloid leukemia (AML) outcomes are very poor in older patients. Haploidentical
stem cell transplantation (haplo-SCT) helps to achieve long-term survival. However, the …
stem cell transplantation (haplo-SCT) helps to achieve long-term survival. However, the …
Pediatric acute myeloid leukemia patients with KMT2A rearrangements: a single-center retrospective study
W Yang, M Qin, C Jia, J Yang, W Chen, Y Luo, Y Jing… - …, 2022 - Taylor & Francis
Purpose Pediatric acute myeloid leukemia (AML) with KMT2A rearrangements has a very
different prognosis. Poor outcomes cannot be avoided even after hematopoietic stem cell …
different prognosis. Poor outcomes cannot be avoided even after hematopoietic stem cell …
[HTML][HTML] Haploidentical transplantation with modified post-transplantation cyclophosphamide for patients with primary aplastic anemia: a multicenter experience
Y Li, N Wang, L Li, Y Cao, J Xu, J Wang… - … and Cellular Therapy, 2021 - Elsevier
Aplastic anemia (AA) is a life-threatening hematological disorder that can be cured by
hematopoietic stem cell transplantation. Haploidentical transplantation becomes an …
hematopoietic stem cell transplantation. Haploidentical transplantation becomes an …
[HTML][HTML] 恶性血液病单倍型造血干细胞移植预处理中兔抗人胸腺细胞球蛋白剂量优化探讨
周茜， 陆铉， 唐亮， 严晗， 陈文兰， 石威… - Chinese Journal of …, 2020 - ncbi.nlm.nih.gov
恶性血液病单倍型造血干细胞移植预处理中兔抗人胸腺细胞球蛋白剂量优化探讨- PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …